United States - English - NLM (National Library of Medicine)

elanco us inc. - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - baytril 100-ca1 is indicated for the treatment of clinical anaplasmosis associated with anaplasma marginale in replacement dairy heifers under 20 months of age and all classes of beef cattle except beef calves less than 2 months of age and beef bulls intended for breeding (any age). not for use in any other class of dairy cattle or in veal calves.

Germany - English - HMA (Heads of Medicines Agencies)

hcs bvba - enrofloxacin 100 mg - oral solution - chicken food, other birds food - enrofloxacin

Ireland - English - HMA (Heads of Medicines Agencies)

hcs bvba - enrofloxacin 100 mg - oral solution - chicken food, other birds food - enrofloxacin

Italy - English - HMA (Heads of Medicines Agencies)

hcs bvba - enrofloxacin 100 mg - oral solution - chicken food, other birds food - enrofloxacin

Netherlands - English - HMA (Heads of Medicines Agencies)

hcs bvba - enrofloxacin 100 mg - oral solution - chicken food, other birds food - enrofloxacin

Ireland - English - HPRA (Health Products Regulatory Authority)

laboratorios calier s.a. - enrofloxacin - solution for injection - 100 milligram(s)/millilitre - enrofloxacin - cattle, pigs - antibiotics

United States - English - NLM (National Library of Medicine)

elanco us inc. - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - zobuxa (enrofloxacin) flavored antibacterial tablets are indicated for the management of diseases associated with bacteria susceptible to enrofloxacin. zobuxa flavored antibacterial tablets are indicated for use in dogs and cats. enrofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones. dogs: based on the studies discussed under the section on animal safety summary, the use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). the safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. large breeds may be in this phase for up to one year of age and the giant breeds for up to 18 months. in clinical field trials utilizing a daily oral dose of 5.0 mg/kg, there were no reports of lameness or joint problems in any breed. however, controlled studies with histological examination of the articular cartilage have not been conducted in the large or giant bre

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

jubaili agrotec limited, tanzania - enrofloxacin - solution for injection - 10

United States - English - NLM (National Library of Medicine)

aspen veterinary resources®, ltd - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin flavored tablets are indicated for the management of diseases associated with bacteria susceptible to enrofloxacin. enrofloxacin flavored tablets are indicated for use in dogs and cats. enrofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones. dogs: based on the studies discussed under the section on animal safety summary, the use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). the safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. large breeds may be in this phase for up to one year of age and the giant breeds for up to 18 months. in clinical field trials utilizing a daily oral dose of 5.0 mg/kg, there were no reports of lameness or joint problems in any breed. however, controlled studies with histological examination of the articular cartilage have not been conducted in the large or giant breeds.

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

intas pharmaceuticals limited., india - enrofloxacin - solution for injection - 10 w/v%